Tracking the CIRM: Affordability of Costly Treatments and the Impact of the Stem Cell and Gene Therapy Effort
The California stem cell and gene therapy program is likely the only significant research funding effort in the nation legally charged with making multimillion-dollar, revolutionary therapies affordable.
California voters delivered the mandate in 2020 when California voters approved $5.5 billion more for the California Institute for Regenerative Medicin…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.